Nox2 activation in brain tissue and Nox2-induced oxidative stress have emerged as a critical factor in the pathogenesis of Alzheimer's disease [121, 122] and Parkinson's disease [116, 123]. This evidence concerns the gene CYBB and early-onset autosomal dominant Alzheimer disease.